Amanote Research
Register
Sign In
Blockade of the Neuropeptide Y Y2 Receptor With the Potent Antagonist BIIE0246 Regulates Gene Expression Levels in the Lipid Metabolic Pathways in Human Hepatoma Cell Line HepG2
Integrative Molecular Medicine
doi 10.15761/imm.1000207
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2016
Authors
Kaji H
Okada M
Hamaue A
Mori M
Nagai M
Publisher
Open Access Text Pvt, Ltd.
Related search
The Role of the Neuropeptide Y2 Receptor in Liporemodeling: Neuropeptide Y–Mediated Adipogenesis and Adipose Graft Maintenance
Plastic and Reconstructive Surgery
Surgery
Expression Cloning and Pharmacological Characterization of a Human Hippocampal Neuropeptide Y/Peptide YY Y2 Receptor Subtype
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Thymoquinone Regulates Gene Expression Levels in the Estrogen Metabolic and Interferon Pathways in McF7 Breast Cancer Cells
International Journal of Molecular Medicine
Medicine
Genetics
Expression of Neuropeptide Y Is Increased in an Activated Human HSC Cell Line
Scientific Reports
Multidisciplinary
Selective Attenuation of Metabolic Branch of Insulin Receptor Down-Signaling by High Glucose in a Hepatoma Cell Line, HepG2 Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Neuropeptide Y and Its Y2 Receptor: Potential Targets in Neuroblastoma Therapy
Oncogene
Cancer Research
Genetics
Molecular Biology
Marked Decrease of Neuropeptide Y Y2 Receptor Binding Sites in the Hippocampus in Murine Prion Disease
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Chronic Ethanol Treatment Depletes Glutathione Regeneration Capacity in Hepatoma Cell Line HepG2
Journal of Cellular Biotechnology
Applied Microbiology
Biotechnology
Molecular Biology
Differences in TCDD-elicited Gene Expression Profiles in Human HepG2, Mouse Hepa1c1c7 and Rat H4IIE Hepatoma Cells
BMC Genomics
Biotechnology
Genetics
